CTLA4 and melanoma: Appallingly, unlike IFNγR1KD melanomas9, IFNγR1KO melanomas had markedly reduced CD8+ T cells at the baseline and no increased T cell infiltration upon anti-CTLA-4 therapy, as compared to scrambled control melanomas (Fig. 2a).